---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-030207"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T12:17:55.532250+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nephros Q3 net revenue $2.4M (-7% YoY); net loss widens to $1.3M; sells PDS business

## Summary
- Net revenue from continuing operations $2.4M, down 7% vs Q3 2021; net loss $1.3M vs $0.8M.
- Adjusted EBITDA loss from continuing operations -$0.3M, improving from -$0.4M in prior year.
- Active Customer Sites grew 18% YoY to a record 1,391; price pull-ahead in Q2 hurt revenue.
- Sold Pathogen Detection Systems (PDS) business; reduces quarterly expenses by ~$300K.
- Cash and equivalents $3.9M at Sept 30, 2022; management targets positive cash flow by mid-2023.

## SEC filing metadata
- accession: 0001493152-22-030207
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/0001493152-22-030207-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-030207
- JSON: https://secwatch.observer/filing/0001493152-22-030207.json
- Plain text: https://secwatch.observer/filing/0001493152-22-030207.txt

## Key facts
- Earnings Releases
  NEPHROS INC reported the third quarter ended September 30, 2022 results: revenue $2.4 million, net income $1.3 million.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $2.4 million
  - Net income: $1.3 million
  - Result: reported results
  source text: Net revenue from continuing operations for the quarter ended September 30, 2022, was $2.4 million, compared to $2.6 million in the corresponding period in 2021, a decrease of 7%. Net loss from continuing operations for the quarter ended September 30, 2022, was $1.3 million, compared to $0.8 million during the same period in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/0001493152-22-030207-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.